The Kenya Medical Research Institute (KEMRI) is relying on its locally produced products following the decision by United States President Donald Trump to cut foreign aid. This move has significantly impacted the organisation’s operations.
KEMRI Director General (DG), Prof. Elijah Songok, stated that areas affected include disinfectants, repellents, Personal Protective Equipment (PPEs), and diagnostic kits, which are crucial for generating revenue and sustaining critical research programmes.
Songok revealed that the funding cuts have affected 40% of the institute’s programmes, putting approximately 824 staff members at risk of losing their jobs.
Of these, according to the official, 90% are involved in research projects in Kisumu, a region where KEMRI has been instrumental in conducting health research, particularly in the fight against malaria, HIV/AIDS, and other infectious diseases.
“At the moment, we can only support 64 staff members from the affected programmes using our internally generated revenue,” Prof. Songok said.
He noted that to keep the projects afloat, KEMRI was ramping up the production and sale of its health-related products to bridge the financial gap.
“We are advocating for players in the health sector to buy our products. We must support KEMRI by purchasing these products in order to minimise the impact of the donor cuts,” he said.
Speaking in Kisumu, Prof. Songok said that in response to the financial strain affecting USAID-funded programmes, KEMRI was now looking beyond traditional Western donors and seeking support from Asian countries, particularly Japan and South Korea.
According to Prof. Songok, these nations have shown promise as potential partners willing to invest in scientific research and health programmes in Africa.
The research institute remains hopeful that diversifying funding sources and leveraging local innovation will help sustain its research agenda, ensuring that critical health studies do not come to a standstill despite external financial challenges.
YOU MAY ALSO READ:
SASRA publishes list of approved external auditors for Saccos in the year 2025
The funding crisis follows President Donald Trump’s “America First” policy, which has led to significant cuts in U.S. foreign aid, including health programmes in developing nations.
His administration has also reduced funding for global health initiatives, dealing a major blow to institutions like KEMRI, which had relied heavily on U.S. grants for research on diseases affecting millions of Kenyans.
“This is not the first time we are encountering this. In 2015, we had a similar problem when the Centre for Disease Control (CDC) pulled out, affecting a number of our programmes.
However, Covid-19 taught us many lessons; that is why we have become innovative and ventured into the production of various products,” he said.
By Fredrick Odiero.
Get more stories from our website: Sacco Review.
For comments and clarifications, write to: Saccoreview@
Kindly follow us via our social media pages on Facebook: Sacco Review Newspaper for timely updates
Stay ahead of the pack! Grab the latest Sacco Review newspaper!
